Brilliant Violet 785(TM) anti-mouse CD4 100551 from BioLegend

Product Specs
ItemBrilliant Violet 785(TM) anti-mouse CD4
CompanyBioLegend
Price Pricing Info Supplier Page View Company Product Page
Catalog Number100551
Quantity125 µL
ApplicationsFlow Cytometry (FC)
Conjugate/TagBrilliant Violet 785™
ReactivityMouse
IsotypeIgG2a, Kappa
CloneRM4-5
HostRat
Antibody TypePrimary
NCBI Gene AliasesL3T4, Ly-4
NCBI Full Gene NameCD4 antigen
FormatPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
ImmunogenBALB/c mouse thymocytes
ClonalityMonoclonal
TargetCD4

Add to Compare List

BioLegend

8999 BioLegend Way

San Diego, California 92121

United States

Phone: 1-877-246-5343 Toll-Free, USA & Canada
1-858-768-5800 International
Fax: 1-877-455-9587

Company Profile

Website: biolegend.com

(1) An in situ hydrogel-mediated chemo-immunometabolic cancer therapyNature communicationsJuly 2, 2022Wang B, Chen J, Caserto JS, Wang X, Ma M.103011, IM7, 1:200), CD4-APC-Cy7 (Tonbo Biosciences 25-0041-U025, GK1.5, 1:200), CD4-BV785 (BioLegend 100551, RM4-5, 1:200), CD4-AlexaFluor 594 (BioLegend 100446, GK1.5, 1:200), IL2-FITC (BioLegend 503805, JES6-5H4,

(2) IL-22 initiates an IL-18-dependent epithelial response circuit to enforce intestinal host defenceNature communicationsFebruary 15, 2022Chiang HY, Lu HH, Sudhakar JN, Chen YW, Shih NS, Weng YT, Shui JW.

(3) Control of Spontaneous HPV16 E6/E7 Expressing Oral Cancer in HLA-A2 (AAD) Transgenic Mice with Therapeutic HPV DNA VaccineJournal of Biomedical ScienceDecember 1, 2021Ssu-Hsueh Tseng, Li Liu, Shiwen Peng, Jinhwi Kim, Louise Ferrall, Chien-Fu Hung, T. -C. Wu

(4) Development of a Novel Mouse Model of Spontaneous High-Risk HPVE6/E7–Expressing Carcinoma in the Cervicovaginal TractCancer ResearchSeptember 1, 2021Talia R. Henkle, Brandon Lam, Yu Jui Kung, John Lin, Ssu-Hsueh Tseng, Louise Ferrall, Deyin Xing, Chien-Fu Hung, T.-C. WuHorizon,565478 CD25,APC-Fire750,BioLegend,102053 CD3,BV421,BioLegend,100228 CD8,BV650,BioLegend,100741 CD4,BV785,BioLegend,100551 TruStain FcX,N/A,BioLegend,101319 Tumor infiltrate panel.

(5) Delivery of toll-like receptor agonists by complement C3-targeted liposomes activates immune cells and reduces tumour growthJournal of Drug TargetingAugust 9, 2021Alexandra Francian, Ashley Widmer, Troy Olsson, Marisabel Ramirez, Darion Heald, Keaton Rasic, Luke Adams, Holly Martinson, Max KullbergCD127 (#135023), BV510 Ly-6C (#128033), BV605 I-A/I-E (#107639), BV650 F4/80 (#123149), BV785 CD4 (#100551), BV785 Ly-6G (#127645), APC/Cy7 CD8b (#126619), and APC/Cy7 CD103 (#121431) were purchased from BioLegend

(6) Pharmacologic modulation of RNA splicing enhances anti-tumor immunityCellJuly 22, 2021Lu SX, De Neef E, Thomas JD, Sabio E, Rousseau B, Gigoux M, Knorr DA, Greenbaum B, Elhanati Y, Hogg SJ, et al.

(7) Resistance to lethal ectromelia virus infection requires Type I interferon receptor in natural killer cells and monocytes but not in adaptive immune or parenchymal cellsPLoS pathogensMay 1, 2021Melo-Silva CR, Alves-Peixoto P, Heath N, Tang L, Montoya B, Knudson CJ, Stotesbury C, Ferez M, Wong E, Sigal LJ.

(8) Long-term evolution and short-term adaptation of microbiota strains and sub-strains in miceCell host & microbeApril 14, 2021Yilmaz B, Mooser C, Keller I, Li H, Zimmermann J, Bosshard L, Fuhrer T, Gomez de Agüero M, Trigo NF, Tschanz-Lischer H, et al.

(9) Enteric helminth coinfection enhances host susceptibility to neurotropic flaviviruses via a tuft cell-IL-4 receptor signaling axisCellMarch 4, 2021Desai P, Janova H, White JP, Reynoso GV, Hickman HD, Baldridge MT, Urban JF Jr, Stappenbeck TS, Thackray LB, Diamond MS.

(10) Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint BlockadeCancer cellFebruary 8, 2021Srivastava S, Furlan SN, Jaeger-Ruckstuhl CA, Sarvothama M, Berger C, Smythe KS, Garrison SM, Specht JM, Lee SM, Amezquita RA, et al.

(11) Integrin αvβ6-TGFβ-SOX4 Pathway Drives Immune Evasion in Triple-Negative Breast CancerCancer cellJanuary 11, 2021Bagati A, Kumar S, Jiang P, Pyrdol J, Zou AE, Godicelj A, Mathewson ND, Cartwright ANR, Cejas P, Brown M, et al.

(12) Suppression of mucosal Th17 memory responses by acellular pertussis vaccines enhances nasal Bordetella pertussis carriageNPJ vaccinesJanuary 8, 2021Dubois V, Chatagnon J, Thiriard A, Bauderlique-Le Roy H, Debrie AS, Coutte L, Locht C.

(13) Production of the Cytokine VEGF-A by CD4⁺ T and Myeloid Cells Disrupts the Corneal Nerve Landscape and Promotes Herpes Stromal KeratitisImmunityNovember 17, 2020Yun H, Yee MB, Lathrop KL, Kinchington PR, Hendricks RL, St Leger AJ.RESOURCE,SOURCE,IDENTIFIER Antibodies,Antibodies,Antibodies Brilliant Violet 785 anti-muse CD4,BioLegend,Cat#100551; Lot# B259957; RRID AB_11218992 Alexa Fluor 700 anti-mouse CD11b,BioLegend,Cat#101222; Lot#B259438;

(14) Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinomaNeoplasia (New York, N.Y.)October 1, 2020Koivisto CS, Parrish M, Bonala SB, Ngoi S, Torres A, Gallagher J, Sanchez-Hodge R, Zeinner V, Nahhas GJ, Liu B, et al.target,Manufacturer,Catalog #,Concentration CD45,Invitrogen,45-0451-82,1:160 CD3,Life Tech,A27057,1:20 CD4,Biolegend,100551,1:80 CD8a,Biolegend,100751,1:40 CD11b,Biolegend,101205,1:200 Ly6G,Biolegend,127639,1:80 Ly6C,Biolegend,128037,1:40 Live/Dead,Thermo,L23105,1:1000 Antibodies

(15) Differential expression of tissue-restricted antigens among mTEC is associated with distinct autoreactive T cell fatesNature communicationsJuly 24, 2020Lebel MÈ, Coutelier M, Galipeau M, Kleinman CL, Moon JJ, Melichar HJ.

(16) Visualization of T Cell Migration in the Spleen Reveals a Network of Perivascular Pathways that Guide Entry into T ZonesImmunityMay 19, 2020Chauveau A, Pirgova G, Cheng HW, De Martin A, Zhou FY, Wideman S, Rittscher J, Ludewig B, Arnon TI.

(17) Interleukin-17A Serves a Priming Role in Autoimmunity by Recruiting IL-1β-Producing Myeloid Cells that Promote Pathogenic T CellsImmunityFebruary 18, 2020McGinley AM, Sutton CE, Edwards SC, Leane CM, DeCourcey J, Teijeiro A, Hamilton JA, Boon L, Djouder N, Mills KHG.

(18) Immune Landscape of Viral- and Carcinogen-Driven Head and Neck CancerImmunityJanuary 14, 2020Cillo AR, Kürten CHL, Tabib T, Qi Z, Onkar S, Wang T, Liu A, Duvvuri U, Kim S, Soose RJ, et al.

(19) Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell PopulationCell reportsDecember 10, 2019Leylek R, Alcántara-Hernández M, Lanzar Z, Lüdtke A, Perez OA, Reizis B, Idoyaga J.

(20) Natural Tr1-like cells do not confer long-term tolerogenic memoryeLifeOctober 11, 2019Yadava K, Medina CO, Ishak H, Gurevich I, Kuipers H, Shamskhou EA, Koliesnik IO, Moon JJ, Weaver C, Nadeau KC, et al.

Write a Review

(1)

1/14/2019The Antibody Identifies CD4+ Cells Very Well Robert YuanWe wanted to study CD4+ T cells in the diseased vs healthy state, so we used the antibody to stain CD4+ T cells in the lymph nodes. The antibody is clear and works well.
(1)

6/12/2017Brilliant Violet 785 anti-mouse CD4 Antibody for FACS Nupur BhattacharyaI am interested in studying the immune system of the murine colonic lamina propria. Therefore, as a first step we had used a panel of antibodies to check the frequency of different types of immune ... Read Review

Brilliant Violet 785(TM) anti-mouse CD4 from BioLegend

Description

BioLegend

Citations (41)

Reviews

Brilliant Violet 785(TM) anti-mouse CD4 from BioLegend

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map